NCT01062061View on ClinicalTrials.gov

Re-examination Study For Varivax (V210-059 AM2)

CompletedOBSERVATIONAL

Enrollment

754

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Varicella

Interventions

BIOLOGICAL

VARIVAX™

Attenuated live varicella vaccine

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01062061 - Re-examination Study For Varivax (V210-059 AM2) | Biotech Hunter | Biotech Hunter